latest news releases from the newsroom
Changes within Telelogic's Board
MALMO, Sweden, Nov. 30, 2004 (PRIMEZONE) -- Telelogic (Stockholm Exchange:TLOG), today announces that Joakim Westh, due to new assignments within the Ericsson Group as of December 1st, wishes to resign as member of the Telelogic Board of Directors. Ericsson is since many years a customer of Telelogic. In his new assignment at Ericsson, Joakim Westh will be in charge of the corporate function Operational Excellence, which among others includes the purchasing department. In order to ensure avoiding eventual future conflict of interest, Joakim Westh hence chooses to resign as Board member at Telelogic as of November 30th 2004.
Millicom International Cellular
Millicom International Cellular S.A. Announces: Concurrent Offerings of 8 Million Ordinary Shares in the form of Ordinary Shares or Swedish Depositary Receipts and US$175 Million Convertible Bonds
BERTRANGE, Luxembourg, Nov. 30, 2004 (PRIMEZONE) -- Millicom International Cellular S.A. ("Millicom") (Nasdaq:MICC) (Stockholmsborsen and Luxembourg Stock Exchange: MIC), today announces that it intends to offer 8 million of its Ordinary Shares in the form of Swedish Depositary Receipts (``SDRs") or Ordinary Shares (the "Share Offering") and that it intends to offer $175 million of convertible bonds convertible into Ordinary Shares and/or SDRs (the "Bonds", or the "Bond Offering"). The offerings, which are subject to market and other conditions, are being made without preferential rights for shareholders, outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act of 1933 (the "Act") or in other transactions exempt from U.S. registration requirements. An additional amount of up to 1 million Ordinary Shares in the form of Ordinary Shares or SDRs and an additional 15% aggregate principal amount of Bonds may be issued upon the exercise of options granted to the managers of the transaction.
Graham Dixon joins Galapagos as Chief Scientific Officer
MECHELEN, Belgium and LEIDEN, The Netherlands, Nov. 30, 2004 (PRIMEZONE) -- Galapagos announced today that Graham Dixon has been appointed Chief Scientific Officer (CSO). Dr. Dixon will be responsible for directing the target selection and drug discovery research at Galapagos. As a result of the progress that the company has made in target identification and validation over the past five years, Galapagos is progressing into a new phase whereby it is developing drugs based on its proprietary drug targets in core disease areas and building the necessary drug discovery infrastructure.
AB Volvo Repurchase 250,000 B shares
GOTEBORG, Sweden, Nov. 30, 2004 (PRIMEZONE) -- Further to the decision taken by AB Volvo's Board of Directors on June 17, 2004, regarding repurchase of own shares, AB Volvo has, on Monday, November 29, acquired 250,000 series B shares. The shares were traded between SEK 276.00 and 277.50 with an average price of SEK 276.68.
Ohio Art Company
The Ohio Art Company Announces the Sale of Its Strydel Division
BRYAN, Ohio, Nov. 29, 2004 (PRIMEZONE) -- The Ohio Art Company, (Pink Sheets:OART), today announced an agreement to sell its Strydel Diversified Products division to May and Scofield, LLC. The terms of the sale were not disclosed. The Strydel transaction is contingent upon the occurrence of certain conditions that must be met prior to the transfer of Strydel's assets. The effective date for the transfer is expected to be no later than March 31, 2005. There can be no assurance, however, that the closing will occur.